129 related articles for article (PubMed ID: 32321926)
1. Complete paraplegia with diffuse osteolytic skeletal metastases: an uncommon presentation of carcinoma of the prostate.
Gupta A; Gahlot N; Elhence P
Spinal Cord Ser Cases; 2020 Apr; 6(1):25. PubMed ID: 32321926
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. [A case of prostate cancer associated with osteolytic bone metastases].
Migita T; Maeda K; Ogata N
Hinyokika Kiyo; 1999 May; 45(5):371-4. PubMed ID: 10410324
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
5. Should prostate cancer be considered as a differential diagnosis in patients with osteolytic bone lesions?
Bakhsh MU; Lee S; Ahmad S; Takher J; Pareek A; Syed U; Seashore J; Szemraj E
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4791-4. PubMed ID: 26744870
[TBL] [Abstract][Full Text] [Related]
6. Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone.
Lee Y; Schwarz E; Davies M; Jo M; Gates J; Wu J; Zhang X; Lieberman JR
J Orthop Res; 2003 Jan; 21(1):62-72. PubMed ID: 12507581
[TBL] [Abstract][Full Text] [Related]
7. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
Clin Nucl Med; 2015 May; 40(5):e265-70. PubMed ID: 25783519
[TBL] [Abstract][Full Text] [Related]
8. [A case of prostatic carcinoma with osteolytic bone metastases].
Fukuoka H; Ishibashi Y; Masuda M; Gotoh A; Murai T; Kitamura H
Hinyokika Kiyo; 1988 Oct; 34(10):1805-9. PubMed ID: 3245528
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
10. [Scientigraphic hot lesions secondary to osseous metastases in a patient with multiple myeloma].
Ruiz Hernández G; Vázquez Forner C; Fliquete Peris MV
Rev Esp Med Nucl; 2002; 21(5):362-5. PubMed ID: 12236912
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report.
Segamwenge IL; Mgori NK; Abdallahyussuf S; Mukulu CN; Nakangombe P; Ngalyuka PK; Kidaaga F
J Med Case Rep; 2012 Dec; 6():425. PubMed ID: 23273271
[TBL] [Abstract][Full Text] [Related]
12. Paraplegia and prostatic cancer.
Jameson RM
Eur Urol; 1983; 9(5):267-9. PubMed ID: 6628468
[TBL] [Abstract][Full Text] [Related]
13. Balloon kyphoplasty and additional anterior odontoid screw fixation for treatment of unstable osteolytic lesions of the vertebral body C2: a case series.
Voelker A; von der Hoeh NH; Heyde CE
BMC Musculoskelet Disord; 2018 Jul; 19(1):259. PubMed ID: 30049274
[TBL] [Abstract][Full Text] [Related]
14. [
Janssen JC; Woythal N; Meißner S; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Mol Imaging Biol; 2017 Dec; 19(6):933-943. PubMed ID: 28707038
[TBL] [Abstract][Full Text] [Related]
15. Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord.
Gonzalez-Barcena D; Vadillo-Buenfil M; Cortez-Morales A; Fuentes-Garcia M; Cardenas-Cornejo I; Comaru-Schally AM; Schally AV
Urology; 1995 Feb; 45(2):275-81. PubMed ID: 7531902
[TBL] [Abstract][Full Text] [Related]
16. [The costal osteolytic image and adenocarcinoma of the prostate].
Medicina (B Aires); 1986; 46(1):97-105. PubMed ID: 3807775
[No Abstract] [Full Text] [Related]
17. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
[TBL] [Abstract][Full Text] [Related]
18. Lumbar bone mineral density in prostate cancer patients with bone metastases.
Chang CH; Tsai CS; Jim YF; Wu HC; Lin CC; Kao A
Endocr Res; 2003 May; 29(2):177-82. PubMed ID: 12856804
[TBL] [Abstract][Full Text] [Related]
19. Excess TGF-β mediates muscle weakness associated with bone metastases in mice.
Waning DL; Mohammad KS; Reiken S; Xie W; Andersson DC; John S; Chiechi A; Wright LE; Umanskaya A; Niewolna M; Trivedi T; Charkhzarrin S; Khatiwada P; Wronska A; Haynes A; Benassi MS; Witzmann FA; Zhen G; Wang X; Cao X; Roodman GD; Marks AR; Guise TA
Nat Med; 2015 Nov; 21(11):1262-1271. PubMed ID: 26457758
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.
Autzen P; Robson CN; Bjartell A; Malcolm AJ; Johnson MI; Neal DE; Hamdy FC
Br J Cancer; 1998 Nov; 78(9):1219-23. PubMed ID: 9820184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
